Polyneuron Pharmaceuticals AG Company
![](/storage/logos_100px/Polyneuron Pharmaceuticals AG.jpg)
Polyneuron is pioneering a novel therapeutic approach for the effective and safe treatment of antibody-mediated autoimmune diseases where a pathological role of autoantibodies is well established. Polyneuron’s platform focus is on devastating autoimmune diseases with an unmet medical need.